Literature DB >> 8882199

Prolonged Th2 cell activation and increased viral replication in HIV-Leishmania co-infected patients despite treatment.

B Cacopardo1, L Nigro, W Preiser, A Famá, M I Satariano, J Braner, B M Celesia, B Weber, R Russo, H W Doerr.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8882199     DOI： 10.1016/s0035-9203(96)90538-6

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN： 0035-9203            Impact factor:   2.184


× No keyword cloud information.
  18 in total

1.  Atypical lesions as a sign of cutaneous dissemination of visceral leishmaniasis in a human immunodeficiency virus-positive patient simultaneously infected by two viscerotropic Leishmania species.

Authors:  Joanna R Santos-Oliveira; Alda M Da-Cruz; Lucy H S Pires; Elisa Cupolillo; Katrin Kuhls; Carmem B W Giacoia-Gripp; Manoel P Oliveira-Neto
Journal:  Am J Trop Med Hyg       Date:  2011-07       Impact factor: 2.345

2.  High levels of CD4⁺ CTLA-4⁺ Treg cells and CCR5 density in HIV-1-infected patients with visceral leishmaniasis.

Authors:  A Vallejo; M Abad-Fernández; S Moreno; A Moreno; M J Pérez-Elías; F Dronda; J L Casado
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-08-21       Impact factor: 3.267

Review 3.  Leishmania and human immunodeficiency virus coinfection: the first 10 years.

Authors:  J Alvar; C Cañavate; B Gutiérrez-Solar; M Jiménez; F Laguna; R López-Vélez; R Molina; J Moreno
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

4.  Low sensitivity of peripheral blood smear for diagnosis of subclinical visceral leishmaniasis in human immunodeficiency virus type 1-infected patients.

Authors:  J Delgado; J A Pineda; J Macías; C Regordán; J A Gallardo; M Leal; A Sanchez-Quijano; E Lissen
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

Review 5.  Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection.

Authors:  S D Lawn; S T Butera; T M Folks
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

6.  Prevalence of and factors associated with visceral leishmaniasis in human immunodeficiency virus type 1-infected patients in southern Spain.

Authors:  J A Pineda; J A Gallardo; J Macías; J Delgado; C Regordán; F Morillas; F Relimpio; J Martín-Sánchez; A Sánchez-Quijano; M Leal; E Lissen
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

7.  Dynamics of serum cytokines in patients with visceral leishmaniasis and HIV-1 co-infection.

Authors:  F J Medrano; C Rey; M Leal; C Cañavate; A Rubio; A Sánchez-Quijano; J Alvar; E Lissen
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

8.  CCR5 and CCR3 expression on T CD3+ lymphocytes from HIV/Leishmania co-infected subjects.

Authors:  L Nigro; M L Rizzo; C Vancheri; R La Rosa; C Mastruzzo; V Tomaselli; A Ragusa; R Manuele; B Cacopardo
Journal:  Med Microbiol Immunol       Date:  2007-04-25       Impact factor: 3.402

Review 9.  The relationship between leishmaniasis and AIDS: the second 10 years.

Authors:  Jorge Alvar; Pilar Aparicio; Abraham Aseffa; Margriet Den Boer; Carmen Cañavate; Jean-Pierre Dedet; Luigi Gradoni; Rachel Ter Horst; Rogelio López-Vélez; Javier Moreno
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

10.  Real-time PCR assay for clinical management of human immunodeficiency virus-infected patients with visceral leishmaniasis.

Authors:  Simona Bossolasco; Giovanni Gaiera; Davide Olchini; Maurizio Gulletta; Leonardo Martello; Arabella Bestetti; Laura Bossi; Luca Germagnoli; Adriano Lazzarin; Caterina Uberti-Foppa; Paola Cinque
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.